Worldwide Clients
+ Studies
+ Experts
+ Years of cumulated experience
OUR MISSION:
We provide cutting-edge CNS electrophysiology solutions, delivering reliable data to empower pharmaceutical and biotech clients in developing new neurological treatments for patients.
OUR VISION :
As the global leader in CNS electrophysiology CRO, we accelerate drug discovery by crafting custom research solutions, constantly leveraging the latest R&D to offer unparalleled personalized protocols.
Despite the negative outcome of the study, we were very impressed with the high quality and speed of the work. Short-notice modifications were implemented professionally, and results were presented in a structured, concise manner. We look forward to potential future projects
I want to thank the Neuroservices-Alliance team for the fantastic high-quality data generated, this was an extremely successful study that peaked a lot of interest across the organization.
I want to express my gratitude for the outstanding collaboration we’ve shared. It has been a terrific experience working with Neuroservices-Alliance, and we greatly appreciate the quality of the science performed at your company.
The Neuroscience community is small, and I am certain that our paths will cross again in the future.
Jeff and his team did a fantastic job with some very challenging spinal cord slice electrophysiology experiments for our project and provided high quality decisional data…very well done!
Neuroservices-Alliance came highly recommended for their NHP DRG ephys services. We found their data quality and communication to be excellent (5/5). Their superior data accuracy, turnaround time, scientific relevance, and overall customer experience truly set them apart, far ahead of other CROs we've worked with. Their team was very responsive and supportive, and their solid data directly led to a critical 'no-go' decision for our compound. We warmly recommend them. Amazing, stimulating, and productive
 |
MAXWELL BIOSYSTEMS MaxWell Biosystems is a technology leader providing high-content electrophysiology platforms advancing scientific discoveries and accelerating drug discovery for neurodegenerative diseases. Neuroservices-Alliance’s affiliate Neuroservice and MaxWell Biosystems’ strategic partnership aims to provide the pharmaceutical industry with a new state-of-the-art CNS in vitro cellelectrophysiological solution based on high-density microelectrode array recording of human iPSC-derived neurons and other neuron cultures. |
|
|
ANATOMIC INCORPORATED Anatomic Incorporated is a pioneering provider of advanced cellular models for drug discovery and development, specializing in providing researchers access to genuine human neural tissue for basic science and drug development. Neuroservices-Alliance’s collaboration with Anatomic Incorporated allows us to offer innovative research solutions using their RealDRGTM cells. We have already conducted several successful studies for clients utilizing these cells, demonstrating their effectiveness and reliability. For deeper insights, please consult the poster we published together at SfN 2023 here. |
 |
 |
 |
 |
 |
 |
Founded in 2018, Neuroservices-Alliance has a worldwide presence through its USA-, European-, and Asian-based customers.
Thanks to its complementary in vitro and in vivo CNS expert platforms, Neuroservices-Alliance is able to answer questions related to targets and mechanisms of action as well as identify and characterize translational biomarkers from in vitro preclinical assays up to clinical trials.
We provide expert and robust platforms with several focus areas: in vitro (Electrophysiology / Rodents and Human Brain and Spinal Cord Slices & DRG) and in vivo (Electrophysiology / Behavior / Optogenetics). Our areas of expertise are still expanding to serve and to empower our customers’ needs!
